Bruce Berkowitz’s Fairholme Capital Management Reports Stake in Sears Holdings Corp. (SHLD)

In its latest filing, Bruce Berkowitz‘s Fairholme Capital Management has reported ownership of 24.23 million shares of Sears Holdings Corp. (NASDAQ:SHLD). The stake amasses 22.8% and represents an increase from 20.76 million shares held by the fund at the end of the third quarter of 2013.

FAIRHOLME (FAIRX) Bruce Berkowitz

Sears Holdings Corp. (NASDAQ:SHLD) is an integrated retailer with almost 2,500 full-line and specialty retail stores in the United States and Canada and the home of Shop Your Way, a social shopping experience where members have the ability to earn points and receive benefits across a wide variety of physical and digital formats through ShopYourWay.com.

At the end of the third quarter of 2013, Edward Lampert’s Esl Investments owned 33.86 million shares of Sears Holdings Corp. (NASDAQ:SHLD), with a reported value of around $2.01 billion. In January, Mr. Lampert reported receiving around 7,200 shares of Sears Holdings Corp. (NASDAQ:SHLD), where he is the Chief Executive Officer.

Earlier, in December, ESL Investment reduced its stake in Sears Holdings Corp. (NASDAQ:SHLD) to some 51.6 million shares, from more than 55.9 million shares held earlier.

Earlier this month, Sears Holdings Corp. (NASDAQ:SHLD) announced the appointments of Norman Miller and Mark Panzer. Miller is joining the company as senior vice president and president, automotive. Mark Panzer was named as senior vice president and president, pharmacy.

Miller most recently served as president and COO of Dollar Financial Corp, while Panzer, previously, served as president and CEO of Pharmaca Integrative Pharmacy Inc.

Disclosure: none

Recommended reading:

Omega Advisors Raises its Stake in New Residential Investment Corp (NRZ)

Ken Griffin’s Citadel Investment Boosts Its Stake in Beazer Homes USA Inc. (BZH)

Roumell Asset Management Dumps Tecumseh Products Company (TECUA)

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!